| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2025-05-12 | 2025-02-28 | 2021-03-30 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 132.2 | 76.24 | 0.935 |
| Research & Development | 97.73 | 55.82 | 0 |
| Selling, General and Administrative | 34.48 | 20.42 | 0.935 |
| Other Operating Expenses | 0 | 0 | -0 |
| Operating Income | -132.2 | -76.24 | -0.935 |
| Net Non-Operating Interest | 8.41 | 5.06 | 0.383 |
| Interest Income | 8.41 | 5.06 | 0.383 |
| Interest Expense | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 122.4 | 71.18 | -0 |
| Income Before Tax | -1.38 | 0 | -0.552 |
| Income Tax Expense | 0.038 | 0 | 0.038 |
| Income Attributable to Non-Controlling Interest | 0.001 | 0 | 0.001 |
| Net Income | -1.42 | 0 | -0.591 |
| Depreciation and Amortization | -3.09 | 0 | 0.383 |
| EBITDA | -135.3 | -76.24 | -0.552 |
| Earnings Per Share (EPS) | -9.07 | -4.89 | -0.047 |
| Diluted Earnings Per Share | -8.62 | -4.89 | -0.047 |
| Weighted Average Shares Outstanding | 15,022 | 14,585 | 12.5 |
| Diluted Weighted Average Shares Outstanding | 15,022 | 14,585 | 12.5 |
